Related Experiment Video
Updated: Jul 10, 2026

08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Concurrent Brucellosis and Acute Lymphoblastic Leukemia: A Case Report
Parisa Bahramian1, Marziyeh Ghalamkari2, Mahdi Khatuni3
1Hematologist and Medical Oncologist, Tehran University of Medical Sciences, Tehran, Iran, tums.ac.ir.
Case Reports in Hematology
|July 9, 2026
Summary
This case study shows that brucellosis can mimic leukemia symptoms, causing diagnostic delays. Early and repeated testing for brucellosis is vital in febrile hematologic malignancy patients from endemic regions.
Area of Science:
- Hematology
- Infectious Diseases
- Oncology
Background:
- Acute lymphoblastic leukemia (ALL) impairs immunity, increasing infection risk.
- Brucellosis shares nonspecific symptoms with leukemia, complicating diagnosis.
- Co-occurrence of ALL and brucellosis is rare but clinically significant.
Purpose of the Study:
- To report a rare case of concurrent B-cell ALL and brucellosis.
- To emphasize the diagnostic challenges posed by overlapping symptoms.
- To highlight the importance of considering brucellosis in febrile leukemia patients.
Main Methods:
- Case report of a 47-year-old male shepherd from Iran.
- Initial diagnosis of B-cell ALL confirmed by bone marrow aspiration and flow cytometry.
- Management involved chemotherapy (hyper-CVAD, dasatinib) and antibiotics (rifampin, doxycycline) after brucellosis re-diagnosis.
Main Results:
- Patient initially presented with ALL symptoms and negative brucellosis tests.
- Persistent fever led to re-evaluation and positive brucellosis serology, suggesting a prozone effect.
- Integrated treatment resulted in rapid clinical improvement and complete remission of ALL, maintained for 2 years.
Conclusions:
- Brucellosis should be considered in the differential diagnosis of febrile hematologic malignancy patients in endemic areas.
- Overlapping clinical presentations can cause diagnostic delays.
- Repeat serological testing or serial dilutions are crucial for diagnosing brucellosis in immunocompromised patients with persistent suspicion.
